Cardiac Rehabilitation for the Patients With Acute Myocardial Infarction
Launched by TAIPEI MEDICAL UNIVERSITY WANFANG HOSPITAL · Dec 14, 2022
Trial Information
Current as of July 03, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Cased diagnosed with acute myocardial infarction at emergent department and admitted
- • 2. Age over 20 years old
- Exclusion Criteria:
- • 1. AAD cases after admission to ER or the general ward
- • 2. Cases died within admission.
- • 3. Cases refused the treatments.-
About Taipei Medical University Wanfang Hospital
Taipei Medical University Wan Fang Hospital is a leading healthcare institution in Taiwan, renowned for its commitment to advancing medical research and improving patient care. As a prominent clinical trial sponsor, the hospital combines cutting-edge medical technology with a multidisciplinary approach to research, facilitating innovative studies that address critical health challenges. With a focus on ethical standards and patient safety, Wan Fang Hospital collaborates with a network of medical professionals and researchers to contribute valuable insights to the global medical community. Its dedication to excellence in clinical trials underscores its role as a pivotal player in the advancement of healthcare practices and therapeutic developments.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Taipei, , Taiwan
Patients applied
Trial Officials
Shiauyee Chen, Master
Principal Investigator
Department of physical medicine and rehabilitation, Wan Fang Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials